Caffeine among compounds that could combat dementia
For years we have seen
studies noting observational connections between consumption of coffee
and reduced risk of dementia, but it's only been recently that
scientists have started to drill down into the neurological reasons
underpinning these observations. A new study by Indiana University
researchers has revealed how several compounds, including caffeine, help
boost the production of an enzyme that has been shown to protect the
brain against several degenerative neurological disorders.
In previous research,
the team discovered that an enzyme known as NMNAT2 was shown to reduce
the cognitive defects associated with dementia and other degenerative
brain diseases. The enzyme does this by combatting tau, which are
misfolded proteins that can build up as plaques in the brain as we age
and have been linked to numerous neurodegenerative disorders, including
Alzheimer's, Parkinson's and Huntington's diseases and ALS (aka Lou
Gehrig's disease). The enzyme also protects neurons from stress.
Their
most recent research looked at what specific compounds affected
production of the NMNAT2 enzyme in the brain, both in increasing and
decreasing its presence. Screening over 1,280 compounds they identified
24 substances that boosted the production of the NMNAT2 enzyme as well
as noting an additional 13 compounds that had the potential to lower the
enzyme's production.
The two most
significant compounds noted in their research as boosting NMNAT2 enzyme
production were caffeine and rolipram, the latter being a discontinued
drug originally used as an antidepressant in the mid-1990s.
Honing in on the
effects of caffeine, the researchers administered the compound to mice
that had been modified to produce lower levels of NMNAT2. After the
administration of caffeine, these modified mice were shown to begin
producing levels of the enzyme similar to those found in normal mice.
"This work could help
advance efforts to develop drugs that increase levels of this enzyme in
the brain, creating a chemical 'blockade' against the debilitating
effects of neurodegenerative disorders," reported Professor Hui-Chen Lu,
one of the lead authors of the study.
Several observational
studies in recent years have noted a correlation between moderate coffee
consumption and lower instances of dementia, but there have been
notable inconsistencies in the results. The effect of other lifestyle
factors and the variance in how people consume caffeine has resulted in
many meta-studies reaching inconclusive results when trying to ascertain a clear correlation between caffeine intake and lowered cognitive decline.
By
drilling down into what the specific triggers are that produce this
protective enzyme in the brain, researchers hope to gain better insights
into the processes behind degenerative neurological disorders.
"Increasing our
knowledge about the pathways in the brain that appear to naturally cause
the decline of this necessary protein is equally as important as
identifying compounds that could play a role in future treatment of
these debilitating mental disorders," Professor Lu explains.
So non-coffee drinking
senior citizens aren't urged to take up the habit just yet, but
scientists are slowly unlocking more pieces in the puzzle of how to
better combat the rising number of neurodegenerative disorders striking
the minds of millions.
The team's research was published in the journal Scientific Reports.this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.
https://gscrochetdesigns.
https://gseasyrecipes.
https://kneereplacement-
Labels: Alzheimer's, caffeine compounds, combats tau, dementia, enzyme- NMNAT2, neurodegenerative diseases, protects, reduces risk
0 Comments:
Post a Comment
<< Home